December 2024

Independent Data Monitoring Statistician reaffirmed current sample size to remain at N=160 The trial has reached 75% of the targeted enrollment, and topline results continue to be expected in the first half of 2025 NEW HAVEN, Conn., Dec. 12, 2024 /PRNewswire/ — Trevi Therapeutics, Inc. (Nasda

#CorbySafeRides Expands to the West. TORONTO and CALGARY, AB, Dec. 12, 2024 /CNW/ – As the leading manufacturer and distributor of spirits, wines, and ready-to-drink, Corby Spirit and Wine is celebrating its 10-year anniversary of providing Torontonians with an easy, complimentary and accessi

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: